Table 5.
Effects1 of 2 different microbiome metabolic modulator products2 supplemented in the feed in 19 independent trials, on the growth performance of broiler chickens raised in floor pens, evaluated with mixed models.
| Parameter of interest | Negative control (NC) | MMM1 | MMM2 | SEM | F Probability |
|---|---|---|---|---|---|
| cFCR (g feed/g BW gain) | 1.643a | 1.616b | 1.586c | 0.036 | <0.001 |
| Feed intake (g/bird) | 4,335b | 4,386a | 4,261c | 246 | <0.001 |
| Final BW (g/bird) | 2,648b | 2,691a | 2,696a | 125 | <0.001 |
| Mortality (% pen) | 4.17 | 4.16 | 3.73 | 0.61 | 0.48 |
a-dMeans with different superscripts differed at P < 0.05.
Linear mixed-effect models considered MMM Treatment as the fixed effect and nested random effects across Study and Block, using the lme function from the nlme package of R (Pinheiro et al., 2015). The variance function allowed for different SD by the study site.
Two structurally distinct microbiome metabolic modulators (MMM1: Glycodex , Midori USA, Inc., Cambridge, MA; and MMM2: Glycan M2-1, Midori USA, Inc., Cambridge, MA and DSM Nutritional Products, Kaiseraugst, Switzerland) were produced by the catalytic oligomerization of food sugars into tailored glycans (Geremia et al., 2016, 2020a) and tested as a feed ingredient in a subset of a total of 19 trials with broiler chickens.